We are live on ! Find out more
ABPI

Accentia Biopharmaceuticals
ABPI

Delisted

ABPI was delisted on the 3rd of November, 2008.

Back to rankings

2 hedge funds and large institutions have $197 invested in Accentia Biopharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
2
Holders Change
+2
Holders Change %
–
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
HCM
1
Highlander Capital Management
New Jersey
$197 +$197 +16,874 New

ABPI Hedge Fund Activity: Q2 2013 in Review

2 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in Accentia Biopharmaceuticals (ABPI) for Q2 2013, worth a combined $197.

Buyers outnumbered sellers: 2 funds opened new ABPI positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.

  • 2 institutional investors held Accentia Biopharmaceuticals (ABPI) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $197 of Accentia Biopharmaceuticals stock for Q2 2013.
  • 2 funds opened new Accentia Biopharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +2 holders.

Based on aggregated 13F filings for Q2 2013.